Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Non-Current Assets (2018 - 2025)

Neurogene (NGNE) has disclosed Non-Current Assets for 5 consecutive years, with $18.3 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Assets fell 11.34% year-over-year to $18.3 million, compared with a TTM value of $77.7 million through Jun 2025, up 8.98%, and an annual FY2024 reading of $19.8 million, changed N/A over the prior year.
  • Non-Current Assets was $18.3 million for Q2 2025 at Neurogene, down from $18.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $21.2 million in Q1 2024 and bottomed at $18.3 million in Q2 2025.